New Partnership Aims to Create Stem Cell Resource to Study Psychiatric Disorders

February 23, 2015

(News-Medical) – The New York Stem Cell Foundation (NYSCF) and the Stanley Center at the Broad Institute of MIT and Harvard are partnering to create a foundational stem cell resource to study psychiatric disorders through the production of induced pluripotent stem (iPS) cell lines from individuals with schizophrenia and other psychiatric disorders.